Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Akihiro Sakai
Affiliation
Tokai University
ORCID
Career Start Year
2002
Papers
91
H Index
20
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37642379
Recurrent Inferior Laryngeal Nerve Preservation During Thyroid Surgery in a Patient with Right Aortic Arch: A Case Report.
Laryngoscope
2024
37955187
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
Head Neck
2024
35075989
Syphilis resembling human papilloma virus associated oropharyngeal cancer: case report and literature review of recent incidence trends.
J Laryngol Otol
2023
37635798
Case report: Cochlear implantation was effective for progressive bilateral severe hearing loss associated with Kawasaki disease.
Front Pediatr
2023
37697390
Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report.
J Med Case Rep
2023
37544719
[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia].
Rinsho Ketsueki
2023
37772758
Shoulder function after neck dissection with level IIb preservation: a prospective observational study.
Acta Otolaryngol
2023
37642856
Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors.
Discov Oncol
2023
37046684
Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Cancers (Basel)
2023
37342106
Salvage transoral videolaryngoscopic surgery for post-irradiation recurrence of hypopharyngeal carcinoma.
Laryngoscope Investig Otolaryngol
2023
36974828
Prognostic Impact of a Novel Albumin-Platelet Index as Selection Criterion for Hepatic Resection in Intermediate Stage Hepatocellular Carcinoma.
Anticancer Res
2023
36999386
Malignant Lymphoma with the MRI Findings Mimicking Inflammatory Disease: A Case Report.
Tokai J Exp Clin Med
2023
36723402
Substrate stiffness induces nuclear localization of myosin regulatory light chain to suppress apoptosis.
FEBS Lett
2023
34729653
Mac-2-Binding Protein Glycosylation Isomer as a Novel Predictor of Hepatocellular Carcinoma Recurrence in Patients with Hepatitis C Virus Eradication.
Ann Surg Oncol
2022
35726111
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9.
Ann Surg Oncol
2022
35780212
ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9.
Ann Surg Oncol
2022
36451679
Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions.
Front Surg
2022
36073278
A Study of Patients with Recurrent or Metastatic Head and Neck Cancer Treated with Pembrolizumab.
Tokai J Exp Clin Med
2022
36090801
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.
Ther Adv Med Oncol
2022
35884375
Good and Bad Stroma in Pancreatic Cancer: Relevance of Functional States of Cancer-Associated Fibroblasts.
Cancers (Basel)
2022
35186711
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.
Front Oncol
2022
34883119
The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
Gastroenterology
2022
33454878
Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
Ann Surg Oncol
2021
33794725
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
Acta Otolaryngol
2021
33491747
Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.
Int J Oncol
2021
33595141
Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma.
Histopathology
2021
33725205
ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
Ann Surg Oncol
2021
34667847
Tumor detection with transoral use of flexible endoscopy for unknown primary head and neck cancer.
Laryngoscope Investig Otolaryngol
2021
34216483
A p16 Positive M1 Oral Tongue Cancer Completely Responsive to the EXTREME Regimen: A Case Report.
Tokai J Exp Clin Med
2021
34216481
Immunohistochemical Marker Expression in Temporal Bone Squamous Cell Carcinoma.
Tokai J Exp Clin Med
2021
34009732
Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma.
Cancer Sci
2021
34194782
Gardner syndrome with odontogenic sinusitis: A case report.
Clin Case Rep
2021
33459371
Computed Tomography to Diagnose Paranasal Sinus Chemical Burns and Tissue Damage: A Case Report.
Laryngoscope
2021
32848210
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.
Oncogene
2020
31721164
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Cancer
2020
31764219
Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model.
Am J Surg Pathol
2020
32103349
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.
Virchows Arch
2020
31850594
Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
Head Neck
2020
32623805
Nodal diffuse large B-cell lymphoma with neoplastic PD-L1 positivity, but without EBV association: Three cases highlighting an aspect of gray zone lymphoma.
Pathol Int
2020
30933315
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Cancer
2019
31448398
Evaluation of Nasal Airflow and Resistance: Computational Modeling for Experimental Measurements.
Tokai J Exp Clin Med
2019
31097695
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nat Commun
2019
31142745
Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nat Commun
2019
28867454
Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone.
Auris Nasus Larynx
2018
29945995
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Clin Cancer Res
2018
29993139
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
Histopathology
2018
30070359
Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Int J Cancer
2018
29920948
How to improve the endoscopic view of the hypopharynx: Validation of our novel modified Killian's Method to expose the hypopharynx in 20 subjects.
Clin Otolaryngol
2018
29695575
Laparoscopic Left Hepatectomy for Ruptured Hepatocellular Carcinoma Controlled After Transcatheter Arterial Embolization: Case Report and Review of the Literature.
In Vivo
2018
29593926
Chronological Progression of an Enlarged Styloid Process: A Case Report of Eagle Syndrome.
Case Rep Otolaryngol
2018
1 - 50 of 91
Column Actions
Search
Recommended Authors
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
Stefan Hartmann
University Hospital Wurzburg
Career Start Year
2013
Number of shared co-authors
0
Krupal B Patel
Moffitt Cancer Center
Career Start Year
2013
Number of shared co-authors
0
Ryan K Orosco
university of california san diego
Career Start Year
2010
Number of shared co-authors
5
Farhoud Faraji
University of California San Diego Health
Career Start Year
2008
Number of shared co-authors
12
Ryan Li
Oregon Health & Science University
Career Start Year
2008
Number of shared co-authors
9
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year
2006
Number of shared co-authors
0
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year
2004
Number of shared co-authors
0
Daniel R Clayburgh
Oregon Health & Science University
Career Start Year
2004
Number of shared co-authors
0
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
3
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year
2002
Number of shared co-authors
0
Anthony C Nichols
University of Western Ontario
Career Start Year
2001
Number of shared co-authors
0
Hyunseok Kang
Johns Hopkins University
Career Start Year
2000
Number of shared co-authors
8
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Career Start Year
2000
Number of shared co-authors
0
Jason H Franklin
Queen's University
Career Start Year
1998
Number of shared co-authors
0
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year
1997
Number of shared co-authors
0
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Career Start Year
1997
Number of shared co-authors
13
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
3
Eric J Moore
2Mayo Clinic
Career Start Year
1995
Number of shared co-authors
0
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year
1993
Number of shared co-authors
5
Jonathan C Irish
Princess Margaret Cancer Centre
Career Start Year
1992
Number of shared co-authors
1
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
3
Joseph C Dort
Cumming School of Medicine, University of Calgary
Career Start Year
1990
Number of shared co-authors
0
Charles R Leemans
Location Vrije Universiteit Amsterdam
Career Start Year
1990
Number of shared co-authors
1
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
13
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
1
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Career Start Year
1988
Number of shared co-authors
3
Michael P Hier
Jewish General Hospital, McGill University
Career Start Year
1987
Number of shared co-authors
0
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year
1986
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Mizuo Ando
University of Tokyo
Co-authored papers
15
Joseph A Califano
University of California
Co-authored papers
11
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Co-authored papers
10
Takahito Fukusumi
Osaka University Graduate School of Medicine
Co-authored papers
10
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers
10
Yorihisa Imanishi
International University of Health and Welfare, Narita Hospital
Co-authored papers
9
Chao Liu
Xiangya Hospital, Central South University
Co-authored papers
9
Yuki Saito
Niigata Prefectural Tokamachi Hospital.
Co-authored papers
7
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers
6
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers
6
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers
6
Guorong Xu
Chinese University of Hong Kong
Co-authored papers
6
Sunny Haft
Moores Cancer Center, University of California
Co-authored papers
6
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers
5
Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers
5
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers
5
John Pang
University of Washington
Co-authored papers
4
Pablo Tamayo
University of California San Diego
Co-authored papers
3
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers
3
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
3
Patrick K Ha
University of California San Francisco
Co-authored papers
3
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
3
Jiahuai Han
Co-authored papers
2
Minya Pu
University of California
Co-authored papers
2
Tatsuya Yamasoba
The University of Tokyo
Co-authored papers
2
Karen Messer
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers
2
Kate Medetgul-Ernar
University of California San Diego Health Moores Cancer Center.
Co-authored papers
2
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Co-authored papers
2
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers
1
Jennifer R Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
1 - 30